Medical Device Founders Raising Funding
For MedTech Founders
Investors rarely say no to a good idea. They say no to unanswered questions... what development will really cost, how long until clearance, and what could derail it. Concise Engineering helps founders turn a promising prototype into a funding-ready development plan with realistic milestones, budgets, and a clear regulatory pathway.
Sound Familiar?
- Investors keep asking about cost and timeline, and I can't answer with confidence.
- I've had money committed, then pulled at the last minute.
- I'm not sure which regulatory pathway I'm on, or what it will cost me.
- Every milestone slips, and it's eating the runway I do have.
A Development Plan Investors Can Get Behind
Funding follows confidence. We build the engineering side of your raise... a phased development roadmap tied to real costs, a regulatory strategy matched to your device, and a risk plan that answers diligence questions before they're asked. You walk into the room with a plan built on more than 20 years of taking devices from concept to production.
- Phased roadmap with milestones tied to funding rounds
- Cost and timeline estimates built from engineering, not guesswork
- Regulatory pathway and device classification strategy
- Risk plan that addresses the questions investors raise in diligence
Why Concise Engineering
- Experience you can budget on. Our estimates come from devices that made it to production, not spreadsheets.
- Risk first. We find the setbacks before an investor does, so diligence has fewer surprises.
- Access, not just engineering. Our network of industry experts means your plan covers regulatory, testing, and manufacturing... not just design.
How It Works
- Discovery call - where your device and your raise stand today
- Technical and regulatory assessment
- Roadmap, budget, and risk plan built around funding milestones
- Development support as capital comes in
Frequently Asked Questions
What do investors look for in a medical device startup?
Beyond the idea, investors want to see a clear regulatory pathway, a realistic development budget, a timeline they can believe, and a team that has thought through the risks. Most early-stage raises stall on the second and third. A credible engineering plan answers those questions before they become objections.
How much does it cost to develop a medical device?
It depends on device class, complexity, testing requirements, and regulatory pathway, so any single number is misleading. What investors want is a defensible estimate broken into phases. We build that estimate from the engineering up, so every line item has a reason behind it.
Should I bring in an engineering partner before or after I raise?
Before, if you can. Early engineering input shapes how much you ask for and what milestones you commit to. Founders who raise first often discover the budget was built on assumptions that don't survive development, and that's a hard conversation to have with investors.
I already have a prototype. Is it too late to plan?
Not at all. A working prototype is a strong starting point. We assess where it stands against production and regulatory requirements, then build the roadmap from there, so you know what's done, what's left, and what it will take.
What happens if funding falls through mid-development?
A phased plan protects you. Each milestone is defined so work can pause at a clean stopping point without losing progress. When capital comes back, development picks up where it left off instead of starting over.
Got a device and a raise on the horizon? Let's pressure-test the plan before investors do.
Book a Discovery Call
Concise Engineering helps medical device founders prepare for funding by building phased development roadmaps, engineering-based cost and timeline estimates, regulatory pathway strategies, and risk plans that support investor diligence.